Table 3.

Potential chemotherapy drugs recommended based on the R correlation between the π score and the drug sensitivity.

	Positively correlated drug	R	FDR	Negatively correlated drug	R	FDR
BRCA	Ruxolitinib	0.388	<0.0001	SB505124	−0.179	<0.0001
	OF-1	0.383	<0.0001	ERK_2440	−0.104	0.0007
	Gallibiscoquinazole	0.367	<0.0001	BI-2536	−0.084	0.0062
	MN-64	0.363	<0.0001	Sepantronium bromide	−0.067	0.0299
	KRAS (G12C) inhibitor-12	0.362	<0.0001
MESO	AZD8055	0.675	<0.0001	SB505124	−0.338	0.0017
	KU-55933	0.593	<0.0001	Dihydrorotenone	−0.301	0.0055
	Telomerase inhibitor IX	0.564	<0.0001
	MIM1	0.544	<0.0001
	Bortezomib	0.541	<0.0001
SKCM	SB216763	0.611	<0.0001	ERK_6604	−0.299	<0.0001
	AZD8055	0.582	<0.0001	ERK_2440	−0.295	<0.0001
	AMG-319	0.577	<0.0001	SCH772984	−0.230	<0.0001
	PRIMA 1MET	0.571	<0.0001	Trametinib	−0.220	<0.0001
	GSK591	0.558	<0.0001	SB505124	−0.197	<0.0001
GBM	Vorinostat	0.401	<0.0001	Entospletinib	−0.413	<0.0001
	ABT737	0.393	<0.0001	ERK_2440	−0.403	<0.0001
	WEHI 539	0.350	<0.0001	SCH772984	−0.365	<0.0001
	Tamoxifen	0.324	<0.0001	Dasatinib	−0.355	<0.0001
	TAF1_5496	0.280	0.0003	ULK1_4989	−0.333	<0.0001
KIRC	SB505124	0.476	<0.0001	AGI 5198	−0.395	<0.0001
	Erlotinib	0.291	<0.0001	XAV939	−0.354	<0.0001
	OF-1	0.286	<0.0001	AZD8055	−0.351	<0.0001
	BI-2536	0.261	<0.0001	ULK1_4989	−0.324	<0.0001
	IAP_5620	0.253	<0.0001	Topotecan	−0.318	<0.0001
LGG	NVP-ADW742	0.533	<0.0001	KU 55933	−0.460	<0.0001
	SB505124	0.512	<0.0001	Entospletinib	−0.444	<0.0001
	Vorinostat	0.508	<0.0001	XAV939	−0.421	<0.0001
	Linsitinib	0.473	<0.0001	AZD1332	−0.419	<0.0001
	Lapatinib	0.421	<0.0001	AZD8055	−0.405	<0.0001
PAAD	Vorinostat	0.442	<0.0001	SCH772984	−0.499	<0.0001
	BIBR-1532	0.427	<0.0001	Acetalax	−0.492	<0.0001
	Doramapimod	0.424	<0.0001	ERK_6604	−0.484	<0.0001
	Sorafenib	0.417	<0.0001	Sapitinib	−0.480	<0.0001
	TAF1_5496	0.402	<0.0001	Trametinib	−0.459	<0.0001
UVM	Sepantronium bromide	0.306	0.0061	XAV939	−0.235	0.0369
	Docetaxel	0.293	0.0088
	Epirubicin	0.292	0.0091
	SB505124	0.287	0.0104
	Sinularin	0.286	0.0105